AZ-MRC Industry Partnerships for Academic Clinicians

Closing Date: 09/05/2023

Funding for active healthcare professionals currently funded by the MRC to spend time embedded within AstraZeneca to gain knowledge and experience of the regulatory and clinical trial processes involved in the development and registration of a new therapy.

The Medical Research Council (MRC) has launched this opportunity to enable active healthcare professionals currently receiving funding from the MRC to spend up to one year embedded at AstraZeneca in order to gain experience and exposure in clinical drug development.

Successful applicants will gain a detailed understanding of how to design, initiate, and conduct clinical trials. This may include exposure to the regulatory and ethical considerations and regulations required for clinical trials. Applicants will gain skills and knowledge in good clinical practice and will be equipped to lead translational clinical trials in either an academic or industry environment in their future career.

Applicants must be able to:

  • Describe how their current research aligns with and would be enriched by the partnership.
  • Describe how their current research would be managed alongside the partnership and demonstrate how their research is at an appropriate stage to accommodate any pauses or delays arising as a result of the partnership.
  • Explain how current and ongoing commitments (such as teaching, clinical sessions, supervision of staff employed on the MRC award) will be managed for the duration of the award.
  • Demonstrate the added value of the partnership, such as how the partnership will support their personal development and long-term career goals.

Applicants can undertake the partnership either on a full- or -part-time basis. The minimum average commitment for the partnership is 60% full-time equivalent (FTE).

Funding body Medical Research Council (MRC)
Maximum value Discretionary
Reference ID S25024
Category Biotechnology and Biology
Medical Research
Fund or call Fund